tert-Butyl 3-(2-(chloromethoxy)-2-oxoethyl)azetidine-1-carboxylate

Catalog No.: 
ACHHWS844
CAS No.: 
2138265-20-8
Molecular Formula: 
C11H18ClNO4
Molecular Weight: 
263.72
tert-Butyl 3-(2-(chloromethoxy)-2-oxoethyl)azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$214.00InquiryInquiry
250mg98%$427.00InquiryInquiry
1g98%$1257.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(2-(chloromethoxy)-2-oxoethyl)azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(2-(chloromethoxy)-2-oxoethyl)azetidine-1-carboxylate
Molecular FormulaC11H18ClNO4
Molecular Weight263.72
SMILESO=C(N1CC(CC(OCCl)=O)C1)OC(C)(C)C
InChI KeyHVMIPIANOKASJG-UHFFFAOYSA-N
Synonymtert-Butyl 3-[2-(chloromethoxy)-2-oxoethyl]azetidine-1-carboxylate;3-Azetidineacetic acid, 1-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester
CAS No.2138265-20-8

Synthetic Route by SureRoute

1. ACHHWS844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACREOB529 route compound structure diagram
    ACREOB529183062-96-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHHWS844 route product structure diagram
    ACHHWS8442138265-20-8
Inquiry

2. ACHHWS844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACREOB529 route compound structure diagram
    ACREOB529183062-96-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHHWS844 route product structure diagram
    ACHHWS8442138265-20-8
Inquiry

3. ACHHWS844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACREOB529 route compound structure diagram
    ACREOB529183062-96-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHHWS844 route product structure diagram
    ACHHWS8442138265-20-8
Inquiry

Comments (0)